GlassScriptPhysician profile
Cheryl Herrmann
NPI 1063936573
$2,008.79
in general payments reported to CMS, 2019-2025
19 companies · $523 in 2025
The $523 reported for 2025 was more than what 77% of Clinical Nurse Specialist providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.18 · 2022: $294 · 2023: $665 · 2024: $434 · 2025: $523.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,621.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $650.36 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $169.96 | 2023-2025 | Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $153.05 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.68 | 2022-2025 | Jardiance |
| Edwards Lifesciences Corporation | $114.92 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Mallinckrodt Hospital Products INC. | $99.41 | 2024 | Terlivaz |
| Astrazeneca Pharmaceuticals LP | $97.61 | 2022-2023 | Farxiga |
| Teva Pharmaceuticals USA, INC. | $94.52 | 2025 | Austedo Xr |
| Scpharmaceuticals INC. | $94.46 | 2023-2025 | |
| Molnlycke Health Care US, LLC | $92.91 | 2023 | Mepilex Border Sacrum, Mepilex Border Post-Op, Exufiber |
| Novo Nordisk INC | $85.48 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $77.84 | 2024 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $37.63 | 2025 | |
| Pfizer INC. | $25.87 | 2022 | |
| Merck Sharp & Dohme LLC | $23.43 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $21.33 | 2023 | Inpefa |
| Abiomed | $20.60 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.24 | 2024 | Xarelto |
| Medtronic, INC. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Herrmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.